We are live on
!
Find out more
JGUA
John G. Ullman & Associates Portfolio holdings
AUM
$754M
1-Year Est. Return
60.05%
This Fund
S&P 500
This Quarter
Est. Return
-0.64%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$722M
AUM Growth
-$5.37M
(-0.74%)
Cap. Flow
+$9.35M
Cap. Flow
% of AUM
1.3%
Top 10 Holdings %
Top 10 Hldgs %
34.36%
Holding
174
New
12
Increased
38
Reduced
77
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moody's
MCO
|
+$4.85M |
| 2 |
ArcBest
ARCB
|
+$3.28M |
| 3 |
Rivian
RIVN
|
+$2.68M |
| 4 |
Aptiv
APTV
|
+$2.38M |
| 5 |
3M
MMM
|
+$2.33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elanco Animal Health
ELAN
|
+$4.59M |
| 2 |
Chewy
CHWY
|
+$2.85M |
| 3 |
BCE
BCE
|
+$2.18M |
| 4 |
OCDX
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
|
+$2.04M |
| 5 |
Vontier
VNT
|
+$1.63M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.31% |
| 2 | Healthcare | 22.21% |
| 3 | Utilities | 18.27% |
| 4 | Industrials | 17.38% |
| 5 | Energy | 5.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Amphenol
APH
$209B
| $227K | 0.03% |
6,012
| – | – |
|
152
Gilead Sciences
GILD
$165B
| $226K | 0.03% |
3,800
| – | – |
|
153
Alphabet (Google) Class C
GOOG
$4.32T
| $226K | 0.03% |
1,620
+220
| +16% | +$29.9K |
|
154
Micron Technology
MU
$991B
| $223K | 0.03% |
2,863
| – | – |
|
155
Accenture
ACN
$108B
| $222K | 0.03% |
659
+29
| +5% | +$9.78K |
|
156
iShares Biotechnology ETF
IBB
$9.77B
| $222K | 0.03% |
1,700
| – | – |
|
157
FirstEnergy
FE
$27.5B
| $220K | 0.03% |
+4,800
| New | +$203K |
|
158
Johnson & Johnson
JNJ
$625B
| $213K | 0.03% |
1,202
-382
| -24% | -$65K |
|
159
Marathon Petroleum
MPC
$83.7B
| $211K | 0.03% |
+2,463
| New | +$187K |
|
160
Palo Alto Networks
PANW
$297B
| $205K | 0.03% |
+1,974
| New | +$177K |
|
|
MXF
161
Mexico Fund
MXF
$315M
| $176K | 0.02% |
10,600
| – | – |
|
162
AmeriServ Financial
ASRV
$83.5M
| $100K | 0.01% |
24,700
| – | – |
|
|
163
Chewy
CHWY
$9.63B
| – | – |
-48,300
| Closed | -$2.85M |
|
164
Estee Lauder
EL
$32B
| – | – |
-558
| Closed | -$207K |
|
165
IPG Photonics
IPGP
$3.84B
| – | – |
-1,650
| Closed | -$284K |
|
166
ITT
ITT
$19.1B
| – | – |
-2,400
| Closed | -$245K |
|
|
167
Vontier
VNT
$4.94B
| – | – |
-53,095
| Closed | -$1.63M |
|
|
APTS
168
DELISTED
Preferred Apartment Communities, Inc.
APTS
| – | – |
-62,323
| Closed | -$1.13M |
|
Similar funds
HCM
FSCM
RMC
BEC
GFM
TPW
MWA
PWA
John G. Ullman & Associates's Q1 2022 Portfolio in Review
As of Q1 2022, John G. Ullman & Associates held 174 positions worth $722M, down 0.74% from $727M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
John G. Ullman & Associates's Q1 2022 filing shows 12 new, 38 increased, 77 reduced and 6 closed positions. Its largest new stake was Moody's: 14,425 shares worth $4.87M. The largest sale was Elanco Animal Health, an estimated $4.59M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Healthcare and Utilities.
- John G. Ullman & Associates's largest Q1 2022 buy was Moody's: 14,425 shares worth $4.87M.
- John G. Ullman & Associates added most to 3M in Q1 2022, an estimated $2.33M increase.
- John G. Ullman & Associates's biggest Q1 2022 reduction was Elanco Animal Health, cutting an estimated $4.59M.
- John G. Ullman & Associates fully exited Chewy in Q1 2022, selling an estimated $2.85M.
- John G. Ullman & Associates's ten largest holdings make up 34% of its $722M portfolio in Q1 2022.
- John G. Ullman & Associates opened 12 new positions and closed 6 in Q1 2022.
- John G. Ullman & Associates's portfolio value fell 0.74% quarter-over-quarter to $722M.
Based on John G. Ullman & Associates's 13F filing for Q1 2022, filed 29 Apr 2022.